Factor IIa inhibitors (peptide) binds IIa

Stable Identifier
R-HSA-9603302
Type
Reaction [binding]
Species
Homo sapiens
Compartment
extracellular region
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Factor IIa inhibitors (peptide) binds IIa
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

In the blood coagulation process, prothrombin is proteolytically cleaved to form thrombin (factor IIa) which in turn, acts as a serine protease that converts soluble fibrinogen into insoluble strands of fibrin. Specifically, thrombin converts factor XI to XIa, factor VIII to VIIIa, factor V to Va, fibrinogen to fibrin, and factor XIII to XIIIa. Direct thrombin inhibitors (DTIs) represent a new class of promising anticoagulation agents. DTIs are increasingly being used instead of heparin to provide initial, rapid anticoagulation. Unlike heparin, which requires a mediator (antithrombin) to potentiate anticoagulation, Peptide DTIs can inhibit free and bound thrombin directly. Lepirudin (brand name Refludan) is a recombinant hirudin derived from yeast cells (Weitz et al. 1990). Hirudin is a naturally occurring anticoagulant produced by the salivary glands of medicinal leeches. Bivalirudin (brand name Angiomax, Angiox) is a synthetic analog of hirudin, with a shorter period of binding to thrombin (Gladwell 2002). Desirudin (brand name Iprivask) is another recombinant hirudin derivative that directly inhibits free and fibrin-bound thrombin (Graetz et al. 2011).

Literature References
PubMed ID Title Journal Year
21932952 Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis

Graetz, TJ, Tellor, BR, Smith, JR, Avidan, MS

Expert Rev Cardiovasc Ther 2011
11833835 Bivalirudin: a direct thrombin inhibitor

Gladwell, TD

Clin Ther 2002
2384594 Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

Weitz, JI, Hudoba, M, Massel, D, Maraganore, J, Hirsh, J

J. Clin. Invest. 1990
Participants
Input
Output
Participant Of
hasEvent
Disease
Name Identifier Synonyms
pulmonary embolism 9477 pulmonary embolus, pulmonary artery embolism
Authored
Jassal, B  (2018-03-19)
Reviewed
Gómez-Outes, A  (2018-03-21)
Created
Jassal, B  (2018-03-19)